Aldeyra Therapeutics Inc (NASDAQ:ALDX) price target set to $30.00 by Cantor Fitzgerald

Analyst Ratings For Aldeyra Therapeutics Inc (NASDAQ:ALDX)

Story continues below

Today, Cantor Fitzgerald set its price target on Aldeyra Therapeutics Inc (NASDAQ:ALDX) to $30.00 per share.

There are 4 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Aldeyra Therapeutics Inc (NASDAQ:ALDX) is Buy with a consensus target price of $23.3333 per share, a potential 48.62% upside.

Some recent analyst ratings include

  • 9/13/2018-Aldeyra Therapeutics Inc (NASDAQ:ALDX) has coverage initiated with a Buy ➝ Buy rating
  • 8/10/2018-Aldeyra Therapeutics Inc (NASDAQ:ALDX) had its Buy rating reiterated by Canaccord Genuity with a $27.00 price target
  • 4/9/2018-Aldeyra Therapeutics Inc (NASDAQ:ALDX) had its Hold rating reiterated by Cowen
  • 3/1/2018-Aldeyra Therapeutics Inc (NASDAQ:ALDX) had its Buy rating reiterated by Seaport Global Securities
  • 5/31/2017-Aldeyra Therapeutics Inc (NASDAQ:ALDX) had its Buy rating reiterated by Stifel Nicolaus with a $16.00 price target

Recent Insider Trading Activity For Aldeyra Therapeutics Inc (NASDAQ:ALDX)
Aldeyra Therapeutics Inc (NASDAQ:ALDX) has insider ownership of 16.99% and institutional ownership of 57.83%.

  • On 9/19/2017 Life Sciences Maste Perceptive, Major Shareholder, bought 200,000 with an average share price of $7.25 per share and the total transaction amounting to $1,450,000.00.
  • On 6/30/2017 Life Sciences Maste Perceptive, Major Shareholder, bought 296,007 with an average share price of $4.60 per share and the total transaction amounting to $1,361,632.20.
  • On 2/17/2017 Martin Joseph Joyce, Director, bought 4,444 with an average share price of $4.50 per share and the total transaction amounting to $19,998.00.
  • On 2/17/2017 Stephen J Tulipano, CFO, bought 3,333 with an average share price of $4.50 per share and the total transaction amounting to $14,998.50.
  • On 2/17/2017 Todd C Brady, Insider, bought 22,223 with an average share price of $4.50 per share and the total transaction amounting to $100,003.50.
  • On 2/14/2017 Perceptive Advisors Llc, Major Shareholder, bought 893,025 with an average share price of $4.50 per share and the total transaction amounting to $4,018,612.50.
  • On 5/26/2016 Perceptive Advisors Llc, Major Shareholder, bought 700,000 with an average share price of $5.00 per share and the total transaction amounting to $3,500,000.00.

Recent Trading Activity for Aldeyra Therapeutics Inc (NASDAQ:ALDX)
Shares of Aldeyra Therapeutics Inc closed the previous trading session at 15,42 up +5,53 55,81 % with 14483057 shares trading hands.

An ad to help with our costs